CDNS Form 4: 10b5-1 Sales Total 8,410 Shares, Option Exercise Disclosed
Rhea-AI Filing Summary
Cadence Design Systems insider transactions: Sr. Vice President Chin-Chi Teng executed an option-related acquisition and multiple sales on 08/18/2025 under a Rule 10b5-1 trading plan. The filing reports the exercise (Transaction Code M) of 4,910 non-qualified stock options with an exercise price of $78.76, which resulted in an acquisition entry of 4,910 shares. The reporting person sold a series of share blocks (Transaction Code S) on the same date totaling 8,410 shares at various weighted-average prices reported in footnotes. Beneficial ownership fell from 137,623 shares before the sales to 129,213 shares after the transactions.
The trades were made pursuant to a 10b5-1 trading plan adopted March 7, 2025; multiple weighted-average sale prices and price ranges are disclosed in footnotes. Option vesting is disclosed as 1/48th per month starting March 14, 2020. The form is signed by an attorney-in-fact for the reporting person.
Positive
- Transactions executed under a Rule 10b5-1 trading plan, indicating pre-established compliance with insider trading rules
- Detailed disclosure of weighted-average sale prices and price ranges for each sale tranche, improving transparency
- Option exercise fully disclosed with exercise price ($78.76) and vesting schedule (1/48th per month starting 03/14/2020)
Negative
- Insider sold 8,410 shares, reducing beneficial ownership from 137,623 to 129,213 shares
- Multiple sales on the same date could be viewed by some investors as a material insider liquidity event
Insights
TL;DR: Insider exercised options and sold shares under a 10b5-1 plan, modestly reducing holdings with transparent price ranges disclosed.
The filing shows an option exercise of 4,910 shares at an exercise price of $78.76 and concurrent sales totaling 8,410 shares executed on 08/18/2025. Sales were conducted under a Rule 10b5-1 plan adopted 03/07/2025, with weighted-average sale prices provided in footnotes and ranges disclosed for each sale block. Beneficial ownership declined from 137,623 to 129,213 shares. For investors, this is a routine liquidity event rather than a disclosed change in company fundamentals; the detailed price ranges improve transparency.
TL;DR: Transactions follow a documented 10b5-1 plan and include full explanatory footnotes, indicating procedural compliance and disclosure thoroughness.
The reporting indicates adherence to Rule 10b5-1 via a plan adopted 03/07/2025 and provides weighted-average prices plus explicit price ranges for each sale tranche, which supports compliance and transparency. The exercise and sales on the same date reduced beneficial ownership by 8,410 shares. Vesting terms for the option are noted (1/48th per month from 03/14/2020). No other governance or unusual terms are disclosed in this Form 4.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non- Qualified Stock Option (right to buy) | 4,910 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,910 | $78.76 | $387K |
| Sale | Common Stock | 1,525 | $348.90 | $532K |
| Sale | Common Stock | 1,215 | $349.70 | $425K |
| Sale | Common Stock | 1,520 | $350.99 | $534K |
| Sale | Common Stock | 650 | $351.64 | $229K |
| Sale | Common Stock | 1,520 | $349.11 | $531K |
| Sale | Common Stock | 860 | $350.14 | $301K |
| Sale | Common Stock | 1,120 | $351.40 | $394K |
Footnotes (9)
- F1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted on 3/7/2025 by the Reporting Person.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $348.30 to $349.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $349.335 to $350.0, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $350.445 to $351.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $351.47 to $351.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $348.525 to $349.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $349.825 to $350.595, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $351.11 to $352.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9. Option vests at a rate of 1/48th per month starting on March 14, 2020.
AI-generated analysis. How Rhea-AI works. Not financial advice.